1-1 of 1 results for subject:ADHD
Librarians' tools
- Search time
- 0.175 seconds
- Solr query time
- 0.002 seconds
- Search query
- subject:ADHD
- We searched for
- subject_t:ADHD OR subject_t:ADD OR subject_t:"Attention deficit disorder" OR subject_t:"Attention deficit hyperactivity disorder" OR subject_t:Hyperactivity OR subject_ses:10835
Session
X
2000-01
Type
House
Session
More
2000-01 (1)
Year
Department
Member
Primary member
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Health, what research he is conducting into the incidence of cases of attention deficit and hyperactivity syndrome which may be related to meningitis C injections; what change there has been in recorded cases of attention deficit and hyperactivity disorder between 1st November 1999...
To ask the Secretary of State for Health, what research he is conducting into the incidence of cases of attention deficit and hyperactivity syndrome which may be related to meningitis C injections; what change there has been in recorded cases of attention deficit and hyperactivity disorder between 1st November 1999...
Asked by
Edward O'Hara
(Labour)
Answered by
Yvette Cooper
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
4 April 2001
For answer on
26 April 2001
Answered on
26 April 2001
Mr. O'Hara: To ask the Secretary of State for Health (1) what research he is conducting into the incidence of cases of attention
deficit and hyperactivity syndrome which may be related to meningitis C injections; [157550]
(2) what change there has been in recorded cases of attention deficit and hyperactivity disorder between 1 November 1999 and 28
February 2001; [157554]
(3) how many cases of attention deficit and hyperactivity disorder have been recorded between 1 November 1999 and 28 February 2001,
which are related to yellow cards submitted in connection with meningitis C injections. [157551]
Yvette Cooper: The Medicines Control Agency (MCA) and the Committee on Safety of Medicine (CSM) has received one report through the
Yellow Card Scheme of hyperactivity aggravated in a child with a history of Attention Deficit Hyperactivity Disorder (ADHD) in
association with the meningitis C vaccines. There have been no reports of Hyperkinetic Disorder or any other term related to ADHD.
ADHD is being increasingly recognised in the United Kingdom as a significant mental health problem among children and adolescents
and to a lesser extent, among adults. The National Institute for Clinical Excellence has estimated that approximately 1 per cent. of
all school-aged children (about 69,000 six to 16-year-olds in England) met the diagnostic criteria for Hyperkinetic Disorder, the
more severe type of ADHD. The prevalence of all types of ADHD is considerably higher, around 5 per cent. of school-aged children
(345,000 six to 16-year-olds in England). There are no data on the change in recorded cases of attention deficit and hyperactivity
disorder between 1 November 1999 and 28 February 2001 as this information is not collected centrally.
No research is currently being conducted into the incidence of cases of attention deficit and hyperactivity syndrome which may be
related to meningitis C injections.
Subjects
ADHD; Vaccination; Meningitis
Date
26 April 2001
Reference
367 c329-30W; 157550;157554;157551
House
House of Commons